Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Taigen Biotechnology Co., Ltd.

Clinical trials sponsored by Taigen Biotechnology Co., Ltd., explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

New drug ISM4808 put to the test in healthy volunteers Results expected Nov 2026 (estimated)

Browse trials soon ready across all sponsors →

Not yet recruiting 1

New drug ISM4808 put to the test in healthy volunteers

Knowledge-focused Not yet recruiting

This early-stage study tests the safety and tolerability of a new oral drug called ISM4808 in 86 healthy adults aged 18-55 in China. Participants receive either the drug or a placebo, and researchers monitor for side effects and how the drug moves through the body. The goal is to…

Phase 1 • Sponsor: TaiGen Biotechnology Co., Ltd. • Aim: Knowledge-focused

Last updated Jun 27, 2026 09:05 UTC